Evidence map›Paper›PMID 34031128›Full record

ArticleInfection and immunity2021

A Murine Model for Enhancement of Streptococcus pneumoniae Pathogenicity upon Viral Infection and Advanced Age.

Basma H Joma, Nalat Siwapornchai, Vijay K Vanguri, Anishma Shrestha, Sara E Roggensack, Bruce A Davidson, Albert K Tai, Anders P Hakansson, Simin N Meydani, John M Leong and 1 more

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Basma H Joma *Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Nalat Siwapornchai *Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Vijay K VanguriUMass Memorial Health Care, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Anishma ShresthaDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Sara E RoggensackDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Bruce A DavidsonDepartment of Anesthesiology, University at Buffalo School of Medicine, Buffalo, New York, USA.
Albert K TaiDepartment of Immunology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Anders P HakanssonDepartment of Translational Medicine, Lund University, Malmö, Sweden.
Simin N MeydaniJean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts, USA.
John M LeongDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Elsa N Bou GhanemDepartment of Microbiology and Immunology, University at Buffalo School of Medicine, Buffalo, New York, USA.
Tufts University · USUniversity at Buffalo, State University of New York · USLund University · SEUMass Memorial Health Care · US

Funding

Immunotherapy for acute lung injury secondary to influenzaR01HL151498 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI KNIGHT III, PAUL R · 2020 to 2023
$1.7M
The efficacy of Liposomal Encapsulation of Polysaccharides pneumococcal vaccine in protecting aged hosts against invasive Streptococcus pneumoniae infections in murine modelsR21AG064215 · NIA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BOU GHANEM, ELSA, PFEIFER, BLAINE A. · 2019 to 2020
$436k
Reversing age-related defects in innate and adaptive immune responses to Streptococcus pneumoniae by oral supplementation with vitamin EF31AI122615 · NIAID · TUFTS UNIVERSITY BOSTON · PI ROGGENSACK, SARA · 2016 to 2018
$99k
NHLBI NIH HHS R01 HL151498NIAID NIH HHS F31 AI122615NIA NIH HHS R21 AG064215
6 · The paper itself

Abstract

Streptococcus pneumoniae (pneumococcus) resides asymptomatically in the nasopharynx (NP) but can progress from benign colonizer to lethal pulmonary or systemic pathogen. Both viral infection and aging are risk factors for serious pneumococcal infections. Previous work established a murine model that featured the movement of pneumococcus from the nasopharynx to the lung upon nasopharyngeal inoculation with influenza A virus (IAV) but did not fully recapitulate the severe disease associated with human coinfection. We built upon this model by first establishing pneumococcal nasopharyngeal colonization, then inoculating both the nasopharynx and lungs with IAV. In young (2-month-old) mice, coinfection triggered bacterial dispersal from the nasopharynx into the lungs, pulmonary inflammation, disease, and mortality in a fraction of mice. In aged mice (18 to 24 months), coinfection resulted in earlier and more severe disease. Aging was not associated with greater bacterial burdens but rather with more rapid pulmonary inflammation and damage. Both aging and IAV infection led to inefficient bacterial killing by neutrophils

Indexed as

AgingCoinfectionHost-Pathogen InteractionsAge FactorsAnimalsDisease Models, AnimalDisease SusceptibilityInfluenza A virusMiceOrthomyxoviridae InfectionsPneumococcal InfectionsStreptococcus pneumoniaeVirulenceVirus Diseasesagingcoinfectioncolonizationinflammationinfluenza Aneutrophilssecondary bacterial pneumoniaStreptococcus pneumoniae

Identifiers

PMID34031128
PMCPMC8281274
OpenAlexW3164781720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.